
Validea's guru fundamental report assigned Intuitive Surgical (ISRG) a 77% rating based on Martin Zweig's Growth Investor model, which targets growth stocks with accelerating earnings/sales, reasonable valuations, and low debt. While ISRG demonstrates strong current and long-term earnings growth and low debt, it notably fails on its P/E ratio, earnings persistence, and earnings growth over several past quarters, positioning it just below the 80% threshold for 'some interest' by the strategy. This indicates a mixed fundamental picture for the large-cap medical equipment firm.
Intuitive Surgical, Inc. (ISRG) presents a mixed fundamental profile according to Validea's Growth Investor model, which is based on Martin Zweig's strategy. The company scored a 77%, placing it just below the 80% threshold that typically indicates strategic interest. The analysis reveals a significant acceleration in recent performance, as ISRG passed criteria for current quarter earnings, sales growth rate, and EPS growth relative to both the prior three quarters and its historical rate. Furthermore, the company exhibits a strong balance sheet, passing the test for a low total debt-to-equity ratio, and shows positive insider transaction signals. However, several key flags temper this positive outlook. The stock fails on its P/E ratio, suggesting its valuation is high under this model's criteria. More critically, it fails on measures of "earnings persistence" and "earnings growth rate for the past several quarters," which indicates that the recent strength may not be part of a sustained trend, creating a conflict between its strong current momentum and its less consistent longer-term earnings track record.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment